Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Davies, Stella M; Borowitz, Michael J; Rosner, Gary L; Ritz, Kristin; Devidas, Meenakshi; Winick, Naomi; Martin, Paul L; Bowman, Paul; Elliott, James; Willman, Cheryl; Das, Soma; Cook, Edwin H; Relling, Mary V

Davies, Stella M; Borowitz, Michael J; Rosner, Gary L; Ritz, Kristin; Devidas, Meenakshi; Winick, Naomi; Martin, Paul L; Bowman, Paul; Elliott, James; Willman, Cheryl; Das, Soma; Cook, Edwin H; Relling, Mary V.

Affiliation

Davies SM; Department of Pediatrics, Cincinnati Children's Hospital and Medical Center, OH 45230, USA. stella.davies@cchmc.org

Blood ; 111(6): 2984-90, 2008 Mar 15.

Article in En | MEDLINE | ID: mdl-18182569

Subject(s)

Pharmacogenetics; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics; Child; Female; Genotype; Humans; Male; National Cancer Institute (U.S.); Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/epidemiology; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology; Risk Factors; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Blood Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google